Why the 'mad scramble' to fill hormone therapy prescriptions for menopause
Removal of FDA black-box warning on hormone therapy has increased demand, causing widespread pharmacy shortages of transdermal estrogen patches for menopausal symptom management.
Other Barks & Bites for Friday, May 9: USPTO Responds to GAO Report; Stewart Welcomes National Inventors Hall of Fame Inductees; CAFC Defines 'Ground' for IPR Estoppel Statute
Developments span patent law precedents, trade and supply‑chain agreements for pharmaceuticals, AI and copyright scrutiny, technology export changes, and diagnostic sublicensing to expand African manufacturing.